Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Snowflake Might Be a Terrible Name But Don’t Let That Stop You From Investing

By Will Ashworth, InvestorPlace Contributor

Snowflake has doubled since going public in September. While its company name is kind of silly, the same can’t be said of SNOW stock.  

I’m Sure Warren Buffett Would Love to See Apple Trading Below $100

By Will Ashworth, InvestorPlace Contributor

If Apple hits some more turbulence in 2020 and AAPL stock falls below $100, I'd expect Warren Buffett to add to his holdings.

Carnival Stock Looks Stuck Despite White House Intervention

By Will Ashworth, InvestorPlace Contributor

The White House blocked the CDC’s attempt to keep cruise ships docked until mid-February. Carnival stock looks to have run aground for now.

The Risk-to-Reward Proposition for Sorrento Has Gone Bad

By Will Ashworth, InvestorPlace Contributor

Sorrento Therapeutics shareholders witnessed SRNE stock gain 70% in the past month. The risk-to-reward proposition has gone from good to bad.   

5 Tips for Making Money in Penny Stocks

By Will Ashworth, InvestorPlace Contributor

Like any investment, penny stocks have their share of pros and cons. Here’s what you need to know to make money.

7 IPO Tips to Pick the Next Big SPAC IPO

By Will Ashworth, InvestorPlace Contributor

SPACs have become all the rage in 2020. If you're unsure how to find SPAC winners, here are seven IPO tips to get you started.

If You’re Placing Bets on Vaccine Winners, Novavax Ought to Be on Your List 

By Will Ashworth, InvestorPlace Contributor

Novavax got a manufacturing partner in mid-September to make 2 billion doses. Despite NVAX stock going sideways since then, it remains a buy.   

Workhorse Remains An Excellent Speculative Buy

By Will Ashworth, InvestorPlace Contributor

The demand for last-mile delivery vehicles is providing Workhorse Group with a new lease on life. That's good news for WKHS stock.

10 Small-Cap Stocks to Buy From Some of America’s Best ETFs

By Will Ashworth, InvestorPlace Contributor

The top 10 ETFs for small-cap stocks have average total assets of $3.7 billion. Here are 10 recommendations from each of these ETFs.   

There’s Only One Way Nokia Stock Gets to $6 in the Near Term

By Will Ashworth, InvestorPlace Contributor

The odds Microsoft could be interested in making a play for Nokia are rising. That’s the best chance for Nokia stock to see $6 any time soon. 

Load More